Auranova Resources Inc
Auranova Resources Inc is a mining company focused on gold exploration and production.
Business. Auranova Resources Inc (AURA.V) is a gold mining company operating within the Basic Materials sector. The firm is headquartered in Canada and is primarily listed on the TSX Venture Exchange. Specific details regarding its operating segments and geographic mix are not available.
Analyst recommendations
6 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Auranova Resources Inc (AURA.V) is a gold mining company operating within the Basic Materials sector. The firm is headquartered in Canada and is primarily listed on the TSX Venture Exchange. Specific details regarding its operating segments and geographic mix are not available.
Auranova Resources Inc has a fully diluted share count of 77,089,282 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability and return metrics are not available for Auranova Resources Inc, as no valuation snapshot data is provided. This limits the ability to compare the company's performance against industry benchmarks or preferred metrics for the Gold industry.
Segment and geographic exposure data are not disclosed in the available financial reports, making it difficult to assess revenue concentration or geographic diversification.
Growth trajectory data is not available, as no outlook numeric deltas or revenue history is provided. This limits the ability to assess the company's future performance or growth potential.
Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. Dilution risk is currently low, as there is no difference between basic and diluted shares outstanding.
Recent events, including filings and transcripts, are not disclosed in the available data, limiting insight into the company's recent operational or strategic developments.
- Auranova Resources Inc is a gold mining company with no disclosed profitability or return metrics.
- The company has no dilution risk as basic and diluted shares are equal.
- Liquidity risk could not be assessed due to missing balance-sheet data.
- Growth trajectory and revenue history are not available.
- No recent events or filings are disclosed in the available data.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Stock Option (Right to Buy) → Common StockAcquired 60 000 @ $7,03grant · 2026-07-07
- Director · Stock Option (Right to Buy) → Common StockAcquired 30 000 @ $6,21grant · 2026-06-11
- Director · Stock Option (Right to Buy) → Common StockAcquired 30 000 @ $6,21grant · 2026-06-11
- Director · Stock Option (Right to Buy) → Common StockAcquired 30 000 @ $6,21grant · 2026-06-11
- Director · Stock Option (Right to Buy) → Common StockAcquired 30 000 @ $6,21grant · 2026-06-11
- Director, See Remarks · Stock Option (Right to Buy) → Common StockAcquired 2 169 103 @ $7,39grant · 2026-05-19
- See Remarks · Stock Option (Right to Buy) → Common StockAcquired 128 755 @ $6,14grant · 2026-03-02
- Director, See Remarks · Stock Option (Right to Buy) → Common StockAcquired 249 000 @ $6,14grant · 2026-03-02
- See Remarks · Stock Option (Right to Buy) → Common StockAcquired 112 661 @ $6,14grant · 2026-03-02
- Chief Medical Officer · Stock Option (Right to Buy) → Common StockAcquired 160 944 @ $6,14grant · 2026-03-02
- Chief Technology Officer · Stock Option (Right to Buy) → Common StockAcquired 112 661 @ $6,14grant · 2026-03-02
- Senior Vice President, Finance · Stock Option (Right to Buy) → Common StockAcquired 80 472 @ $6,14grant · 2026-03-02
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Auranova Resources Inc Market data — financials · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$14M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2024-06-300,00 %$23M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$16M
- Investment Managers · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2024-12-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Funds · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Leadership
- Natalie C. HollesPresident, Chief Executive Officer, Director
Insider activity
- Director · Common StockOther 30 000 · 2026-07-07
- See Remarks · Common StockOther 14 858 · 2026-07-01
- See Remarks · Common StockSold 12 824 @ $6,42$82K · 2026-06-16
- Director · Common StockOther 15 000 · 2026-06-11
- Director · Common StockOther 15 000 · 2026-06-11
- Director · Common StockOther 15 000 · 2026-06-11
- Director · Common StockOther 15 000 · 2026-06-11
- Director, See Remarks · Common StockOther 600 118 · 2026-05-19
- Director, See Remarks · Common StockOther 553 844 · 2026-05-19
- 10% owner · Common Stock, par value $0.00001 per share (Common Stock)Sold 6 922 870 @ $5,64$39,0M · 2026-05-07
- See Remarks · Common StockSold 11 738 @ $7,02$82K · 2026-04-16
- See Remarks · Common StockOther 62 339 · 2026-03-02
- Senior Vice President, Finance · Common StockOther 44 528 · 2026-03-02
- Chief Medical Officer · Common StockOther 89 056 · 2026-03-02
- Chief Technology Officer · Common StockOther 62 339 · 2026-03-02
- Director, See Remarks · Common StockOther 166 000 · 2026-03-02
- See Remarks · Common StockOther 71 245 · 2026-03-02
- Senior Vice President, Finance · Common StockSold 8 549 @ $5,06$43K · 2026-02-17
- Chief Medical Officer · Common StockSold 20 401 @ $5,06$103K · 2026-02-17
- Chief Technology Officer · Common StockSold 15 890 @ $5,05$80K · 2026-02-17
- See Remarks · Common StockSold 12 079 @ $5,05$61K · 2026-02-17
- Director, See Remarks · Common StockSold 47 648 @ $5,06$241K · 2026-02-17
- Director, See Remarks · Common StockSold 16 928 @ $4,86$82K · 2026-01-20
- Senior Vice President, Finance · Common StockSold 1 581 @ $4,86$8K · 2026-01-20
- Chief Medical Officer · Common StockSold 17 109 @ $5,42$93K · 2025-11-17
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -6.2%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -64.3%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 87.8%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -9.9%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -7.2%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -22.2%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 23.2%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -17.3%Derived (calculated)
- Return on equity (FY 2025-12-31): -77.6%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -0.6%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 6.5%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.24xDerived (calculated)
- Current ratio (FY 2025-12-31): 8.15xDerived (calculated)
- Return on assets (FY 2025-12-31): -62.7%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -0.6%Derived (calculated)
- EPS (diluted) (annual): USD-PER-SHARES -2SEC XBRL filing
- Operating income (annual): USD -112.79MSEC XBRL filing
- R&D expense (annual): USD 90.3MSEC XBRL filing
- Current liabilities (annual): USD 18.38MSEC XBRL filing
- Shares outstanding (annual): 63.59MSEC XBRL filing
- Shareholders' equity (annual): USD 136.91MSEC XBRL filing
- Operating cash flow (annual): USD -84.74MSEC XBRL filing
- Total assets (annual): USD 169.43MSEC XBRL filing
- Cash & equivalents (annual): USD 59.52MSEC XBRL filing